PASG

Passage Bio (PASG)

Passage Bio Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PASG

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/23	05 : 03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PASG	Passage Bio Inc
2024/05/21	21 : 00	GlobeNewswire Inc.	Passage Bio Announces Recipient of Third Annual Tachi Yamada Scholarship Award	NASDAQ:PASG	Passage Bio Inc
2024/05/14	21 : 15	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:PASG	Passage Bio Inc
2024/05/14	20 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PASG	Passage Bio Inc
2024/05/14	20 : 01	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PASG	Passage Bio Inc
2024/05/14	20 : 00	GlobeNewswire Inc.	Passage Bio Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights	NASDAQ:PASG	Passage Bio Inc
2024/04/22	20 : 00	GlobeNewswire Inc.	Passage Bio to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit	NASDAQ:PASG	Passage Bio Inc
2024/03/05	21 : 00	GlobeNewswire Inc.	Passage Bio Seeks Pennsylvania College Student Candidates for Third Annual Tachi Yamada Scholarship Program	NASDAQ:PASG	Passage Bio Inc
2024/03/05	07 : 22	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:PASG	Passage Bio Inc
2024/03/05	06 : 09	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:PASG	Passage Bio Inc
2024/03/04	21 : 15	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:PASG	Passage Bio Inc
2024/03/04	21 : 02	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PASG	Passage Bio Inc
2024/03/04	21 : 00	GlobeNewswire Inc.	Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights	NASDAQ:PASG	Passage Bio Inc
2024/03/01	06 : 06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PASG	Passage Bio Inc
2024/02/27	21 : 00	GlobeNewswire Inc.	Passage Bio to Participate in Upcoming Investor Conferences	NASDAQ:PASG	Passage Bio Inc
2024/02/14	23 : 21	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:PASG	Passage Bio Inc
2024/02/14	09 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PASG	Passage Bio Inc
2024/02/14	09 : 34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PASG	Passage Bio Inc
2024/01/06	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PASG	Passage Bio Inc
2024/01/04	06 : 21	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PASG	Passage Bio Inc
2024/01/04	06 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PASG	Passage Bio Inc
2024/01/04	06 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PASG	Passage Bio Inc
2023/12/30	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PASG	Passage Bio Inc
2023/12/20	21 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PASG	Passage Bio Inc
2023/12/20	21 : 00	GlobeNewswire Inc.	Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities	NASDAQ:PASG	Passage Bio Inc
2023/11/18	06 : 30	GlobeNewswire Inc.	Passage Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)	NASDAQ:PASG	Passage Bio Inc
2023/11/13	21 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PASG	Passage Bio Inc
2023/11/13	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PASG	Passage Bio Inc
2023/11/13	21 : 00	GlobeNewswire Inc.	Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights	NASDAQ:PASG	Passage Bio Inc
2023/10/30	20 : 00	GlobeNewswire Inc.	Passage Bio to Present at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference	NASDAQ:PASG	Passage Bio Inc